Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 3

Review

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations

          
Total article views   Abstract views HTML views PDF downloads Totals
9,349 Dovepress* 8,263 404+ 4,064 8,667
PubMed Central* 0 682 69 682
Totals 8,263 1,086 4,133 9,349
*Since 4 August 2011
+Since July 2016

View citations on PubMed Central and Google Scholar